Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about APOE4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
APOE4 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 643 entities in the SciDEX knowledge graph.
| Gene Symbol | APOE4 |
| Aliases | apoe4 |
| Associated Diseases | ALS, AMYLOID PLAQUES, Aging, Alzheimer, Alzheimer'S Disease |
| Known Drugs/Compounds | Triacylglycerol, 7C11, lecanemab, trehalose, donanemab, aducanumab |
| Interactions | APOE, ABCA1, INPP5D, NFL, LDLR, TAU |
| SciDEX Hypotheses | Astrocyte-Selective APOE4 Silencing via Lipid Nano |
| KG Connections | 1552 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
APOE4["APOE4"] -->|"contributes to"| amyloid_beta_deposits["amyloid beta deposits"]
APOE4["APOE4"] -.->|"inhibits"| cognition["cognition"]
APOE4["APOE4"] -->|"causes"| amyloid_pathology["amyloid pathology"]
APOE4["APOE4"] -->|"associated"| AMYLOID___PLAQUES["AMYLOID-Beta PLAQUES"]
APOE4["APOE4"] -->|"associated"| TAU_TANGLES["TAU TANGLES"]
APOE4["APOE4"] -->|"causes"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
FN1["FN1"] -->|"protects against"| APOE4["APOE4"]
TREM2["TREM2"] -->|"interacts"| APOE4["APOE4"]
n_7C11["7C11"] -.->|"inhibits"| APOE4["APOE4"]
APP["APP"] -.->|"inhibits"| APOE4["APOE4"]
style APOE4 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| APOE | activates | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| cognitive decline | predicts | process | 1.00 |
| intracellular lipid homeostasis | disrupts | process | 1.00 |
| Alzheimer | expressed_in | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Alzheimer's disease | promotes | disease | 1.00 |
| APOE | expressed_in | gene | 1.00 |
| Stem Cell | activates | pathway | 1.00 |
| late-onset Alzheimer's disease | risk_factor_for | disease | 0.98 |
| Late-Onset Alzheimer's Disease | risk_factor_for | disease | 0.95 |
| Intracellular Lipid Homeostasis | associated_with | process | 0.95 |
| Blood-Brain Barrier Dysfunction | causes | process | 0.95 |
| Tau-Mediated Neurodegeneration | associated_with | process | 0.95 |
| neurodegenerative microglia response | inhibits | process | 0.95 |
| PINK1/Parkin axis | inhibits | pathway | 0.95 |
| Tau Pathology | promotes | phenotype | 0.95 |
| Glial Lipid Accumulation | promotes | phenotype | 0.95 |
| Late-Onset Alzheimer Disease | risk_factor_for | disease | 0.95 |
| cellular lipidome | associated_with | phenotype | 0.95 |
| seizure susceptibility | promotes | phenotype | 0.95 |
| Alzheimer | therapeutic_target | disease | 0.95 |
| Als | associated_with | disease | 0.95 |
| Neurodegeneration | regulates | disease | 0.95 |
| Alzheimer's Disease | risk_factor_for | disease | 0.95 |
| Neuroinflammation | regulates | disease | 0.95 |
| Inflammation | regulates | disease | 0.95 |
| Neurodegeneration | promotes | process | 0.95 |
| Alzheimer'S Disease | risk_factor_for | disease | 0.95 |
| Myelination | associated_with | process | 0.95 |
| mitochondrial dysfunction | promotes | phenotype | 0.94 |
| ITGB8-TGFβ signaling | activates | pathway | 0.93 |
| Lipid Droplet Accumulation | causes | phenotype | 0.92 |
| Alzheimer's Disease | drives | disease | 0.92 |
| Alzheimer's Disease pathology | contributes_to | phenotype | 0.91 |
| amyloid beta deposits | contributes_to | phenotype | 0.90 |
| cognition | inhibits | phenotype | 0.90 |
| amyloid pathology | causes | phenotype | 0.90 |
| Amyloid Pathology | upregulates | process | 0.90 |
| Amyloid Related Imaging Abnormalities | risk_factor_for | phenotype | 0.90 |
| Lipofuscinosis | associated_with | phenotype | 0.90 |
| Tau pathology | promotes | phenotype | 0.90 |
| neurodegeneration | promotes | process | 0.90 |
| neuroinflammation | promotes | process | 0.90 |
| Tau Pathology | associated_with | phenotype | 0.90 |
| Cytoplasmic Lipid Droplet Accumulation | causes | phenotype | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOE3 | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 1.00 |
| ASTROCYTES | activates | gene | 1.00 |
| ALZHEIMER | expressed_in | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| FN1 | protects_against | gene | 0.90 |
| h-541d61c3 | targets_gene | hypothesis | 0.90 |
| TREM2 | regulates | gene | 0.90 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.90 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.90 |
| NEURODEGENERATION | regulates | gene | 0.90 |
| APOE3 | suppresses | protein | 0.85 |
| CYP46A1 | interacts_with | gene | 0.80 |
| VEGF | reverses | protein | 0.80 |
| C1Q | co_expressed_with | protein | 0.80 |
| MICROGLIA-DERIVED APOE2 | modulates | protein | 0.80 |
| TREM2 | binds | gene | 0.80 |
| Prime Editing | corrects | mechanism | 0.80 |
| LXR | regulates | protein | 0.80 |
| h-541d61c3 | targets | hypothesis | 0.80 |
| TAU | activates | gene | 0.80 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.80 |
| ALZHEIMER'S DISEASE | causes | gene | 0.80 |
| TAU PATHOLOGY | activates | gene | 0.80 |
| ALZHEIMER | causes | gene | 0.80 |
| ALZHEIMER | therapeutic_target | gene | 0.80 |
| ALZHEIMER | biomarker_for | gene | 0.80 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.80 |
| APOE2 | protects_against | gene | 0.75 |
| MAPT | interacts_with | gene | 0.75 |
| TREM2 | interacts_with | protein | 0.70 |
| 7C11 | inhibits | drug | 0.70 |
| TAU | inhibits | gene | 0.70 |
| TAU | regulates | gene | 0.70 |
| TAU | implicated_in | gene | 0.70 |
| GAIN | implicated_in | gene | 0.70 |
| TAU | co_localizes | protein | 0.70 |
| APOE | implicated_in | gene | 0.70 |
| APOE2 | associated_with | gene | 0.70 |
| APOE | modulates | gene | 0.70 |
| APOE3 | associated_with | gene | 0.70 |
| NEURODEGENERATION | inhibits | gene | 0.70 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.70 |
| NEURODEGENERATION | associated_with | gene | 0.70 |
| APOE3 | inhibits | gene | 0.70 |
| APOE3 | interacts_with | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.505
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.588
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.473
neurodegeneration | 2026-04-12 | 0 hypotheses
structural biology | 2026-04-12 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591] | Rusmini P, Cortese K, Crippa V, Cristofa | Autophagy | 2019 | 2 |
| Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] | Litvinchuk A, Suh JH, Guo JL, Lin K, Dav | Neuron | 2024 | 1 |
| The cell biology of APOE in the brain. [PMID:37805344] | Windham IA, Cohen S | Trends Cell Biol | 2024 | 1 |
| An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wid [PMID:38753766] | Huang Q, Chan KY, Wu J, Botticello-Romer | Science | 2024 | 1 |
| The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] | Maxine R Nelson, Peng Liu, Ayushi Agrawa | Nature neuroscience | 2023 | 1 |
| ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. [PMID:36348357] | Raulin AC, Doss SV, Trottier ZA, Ikezu T | Mol Neurodegener | 2022 | 1 |
| APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] | Serrano-Pozo A, Das S, Hyman BT | Lancet Neurol | 2021 | 1 |
| APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. [PMID:33658354] | Sienski G, Narayan P, Bonner JM, Kory N, | Sci Transl Med | 2021 | 1 |
| Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] | Banik SM, Pedram K, Wisnovsky S, Ahn G, | Nature | 2020 | 1 |
| Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] | Long JM, Holtzman DM | Cell | 2019 | 1 |
| Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [PMID:31367008] | Yamazaki Y, Zhao N, Caulfield TR, Liu CC | Nat Rev Neurol | 2019 | 1 |
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] | Krasemann S, Madore C, Cialic R, Baufeld | Immunity | 2017 | 1 |
| Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188] | Cetindag AC, Schipke CG, Esselmann H, Kr | The journal of prevention of A | 2026 | 0 |
| Perioperative polygenic and APOE-based genetic risk assessment for neurocognitiv [PMID:40562635] | Thedim M, Hu J, Maher M, Wiener-Kronish | Br J Anaesth | 2026 | 0 |
| Increased genetic protection against Alzheimer's disease in centenarians. [PMID:40615639] | Bae H, Song Z, Ali A, Sasaki T, Tesi N e | Geroscience | 2026 | 0 |
| Integrative machine learning approach to risk prediction for dementia and Alzhei [PMID:40864401] | Stern A, Linial M | Geroscience | 2026 | 0 |
| Adipose Tissue Macrophage-Derived Proplatelet Basic Protein Exacerbates Psoriasi [PMID:40886963] | Zhu L, Du L, Wu J, Ding D, Wang J et al. | J Invest Dermatol | 2026 | 0 |
| Restoration of p53 mRNA combined with BRD4 silencing by brain targeted nanocapsu [PMID:41101204] | Sang Y, Cao Y, Li S, Quan Y, Wang S et a | Biomaterials | 2026 | 0 |
| Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β path [PMID:41445196] | Lin Z, Xiong J, Zhang F, Zhang H, Zhu M | Mol Ther | 2026 | 0 |
| Menopause, cognition, and Alzheimer's disease risk. [PMID:41531227] | Samudra N, Vemuri M, Weitlauf J | Curr Opin Obstet Gynecol | 2026 | 0 |